Form 4: Zimmer Biomet SVP Winkler Reports Stock Transactions

Zimmer Biomet Holdings SVP and CHRO Lori Winkler reported the vesting of restricted stock units, subsequent tax-related share disposal, and the grant of new RSUs.

Summary

• Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc. (ZBH), reported transactions on February 20, 2026, related to her beneficial ownership.
• Acquired 1,845 shares of common stock upon the vesting of previously granted restricted stock units (RSUs).
• Disposed of 683 shares of common stock at a price of $98.62 per share to satisfy tax withholding obligations associated with the RSU vesting.
• Received a new grant of 7,880 Restricted Stock Units (RSUs).
• The newly granted RSUs will vest annually over three years, with the first one-third vesting scheduled for February 20, 2027.
• Following these transactions, Winkler beneficially owns 7,995 shares of common stock and 7,880 Restricted Stock Units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive indicator of continued executive alignment with shareholder interests through long-term equity incentives, reflecting standard and expected compensation practices.

Positives

• The grant of 7,880 new Restricted Stock Units (RSUs) indicates continued long-term incentive and commitment for the SVP and CHRO.
• The acquisition of 1,845 common shares from RSU vesting increases direct equity ownership, aligning executive interests with shareholder value.

Negatives

• The disposal of 683 shares of common stock to satisfy tax withholding obligations reduces the immediate beneficial ownership of common stock.

Future Outlook

The newly granted 7,880 Restricted Stock Units will vest annually over three years, commencing on February 20, 2027, indicating a future equity incentive structure designed to retain and motivate the executive.

Industry Context

StockSavvy.ai notes that executive equity grants and vesting, along with subsequent tax-related share disposals, are standard compensation practices in the medical device industry. These mechanisms are crucial for aligning executive incentives with long-term shareholder value and retaining key talent.

Comparison to Industry Standards

• Executive compensation through Restricted Stock Units (RSUs) with multi-year vesting schedules is a common practice across large-cap companies, including Zimmer Biomet's peers like Stryker (SYK) and Medtronic (MDT).
• The practice of withholding shares to cover tax obligations upon RSU vesting is a standard and widely accepted method for managing equity compensation in the U.S. market.
• The grant of new RSUs reinforces a long-term incentive structure, consistent with best practices aimed at retaining senior leadership and fostering sustained performance, similar to programs observed at leading healthcare technology firms.

Related Party Transactions

• The transactions detailed, including the vesting of restricted stock units and the grant of new units, represent standard executive compensation arrangements between the company and its Senior Vice President and Chief Human Resources Officer, Lori Winkler.

Stakeholder Impact

• Shareholders: The equity grants align the interests of a key executive with long-term shareholder value creation, potentially fostering sustained company performance.
• Employees: Reflects the company's ongoing executive compensation strategy, which can influence broader compensation philosophies and talent retention efforts.

Next Steps

• The next significant event related to these transactions will be the first annual vesting of the newly granted 7,880 Restricted Stock Units on February 20, 2027.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation activities, including RSU vesting and a new grant. Such transactions are standard and do not typically indicate a change in the company's fundamental outlook or warrant a shift in investment strategy based solely on this report.

Keywords

ZBH, Zimmer Biomet, Lori Winkler, Form 4, insider transaction, restricted stock units, RSU, executive compensation, common stock